See details and pictures
Ulf J. Johansson
Elected chairman of the board of the Novo Nordisk Foundation in 2005.
Ulf J. Johansson (born 1945), holds a doctorate of technology. In 1990 he founded Europolitan Holdings AB, a Swedish GSM mobile telephone operator, publicly listed from 1994 to 2003. In 2005 he resigned as chairman of the board of Europolitan Vodafone AB.
Ulf J. Johansson was a member of the board of directors of Novo Nordisk A/S from 1998 to 2005. In 2000 he joined the board of Novo A/S where he is also chairman since 2005. Ulf J. Johansson was also member of the board of the Novo Nordisk Foundation in the period 1998 to 2000.
In 2005 he also became a member of the board of TelefonAB LM Ericsson. He is chairman of the board of directors of Acando AB and Eurostep Group AB, and a member of the board of directors of Trimble Navigation Ltd. From 1998 to 2003 Ulf J. Johansson was chairman of the board of the Royal Institute of Technology in Stockholm, and he has been a member of the Swedish Academy of Engineering Sciences since 1990.
Ulf J. Johansson (born 1945), holds a doctorate of technology. In 1990 he founded Europolitan Holdings AB, a Swedish GSM mobile telephone operator, publicly listed from 1994 to 2003. In 2005 he resigned as chairman of the board of Europolitan Vodafone AB.
Ulf J. Johansson was a member of the board of directors of Novo Nordisk A/S from 1998 to 2005. In 2000 he joined the board of Novo A/S where he is also chairman since 2005. Ulf J. Johansson was also member of the board of the Novo Nordisk Foundation in the period 1998 to 2000.
In 2005 he also became a member of the board of TelefonAB LM Ericsson. He is chairman of the board of directors of Acando AB and Eurostep Group AB, and a member of the board of directors of Trimble Navigation Ltd. From 1998 to 2003 Ulf J. Johansson was chairman of the board of the Royal Institute of Technology in Stockholm, and he has been a member of the Swedish Academy of Engineering Sciences since 1990.
Jørgen Boe
Vice chairman of the board of the Novo Nordisk Foundation since 2000.
Jørgen Boe (born 1946), holds a law degree and is entitled to plead before the Supreme Court of Denmark. From 1971 to 1989 he lectured on legal proceedings at the University of Copenhagen and on commercial law at Copenhagen Business School.
Jørgen Boe is chairman of the boards of directors of Axel Wirenfeldts Fond, Berger Plus Print Promotion A/S, Bondo Kontormøbler A/S, Ernst & Young Foundation, Gudrun & Johannes Lehmanns Legat, Petax A/S, and Totalkredit Pensionsreguleringsfond and member of the board of directors of Novo A/S.
Jørgen Boe is attorney and a partner in the Danish law firm Kromann Reumert since 1977.
Jørgen Boe (born 1946), holds a law degree and is entitled to plead before the Supreme Court of Denmark. From 1971 to 1989 he lectured on legal proceedings at the University of Copenhagen and on commercial law at Copenhagen Business School.
Jørgen Boe is chairman of the boards of directors of Axel Wirenfeldts Fond, Berger Plus Print Promotion A/S, Bondo Kontormøbler A/S, Ernst & Young Foundation, Gudrun & Johannes Lehmanns Legat, Petax A/S, and Totalkredit Pensionsreguleringsfond and member of the board of directors of Novo A/S.
Jørgen Boe is attorney and a partner in the Danish law firm Kromann Reumert since 1977.
Bo Ahrén
Member of the board of the Novo Nordisk Foundation since 2005. He is since 2001 member of the Novo Nordisk Foundation's Nordic Research Committee and chairman from 2005. Member of the Novo Nordisk Foundation's price committee since 2005.
Bo Ahrén (born 1952), holds a doctorate of medicine and is a registered physician. Since 1995 he has been professor of Clinical Metabolism at the Faculty of Medicine at Lund University. Since 2000 he is a consultant at the Department of Endocrinology and Lund University Hospital. During the years 2004-2005 he was the Chief Physician at the Region of Skåne in Sweden.
Bo Ahrén is an active researcher within the field of diabetology. He has published more than 600 original scientific articles and review articles within the are of insulin secretion. His research has during recent years concentrated on incretin actions with particular emphases on developing new treatment for type 2 diabetes based on the incretin hormone GLP-1.
Bo Ahrén has since 2006 been the Dean of the Faculty of Medicine at Lund University.
Bo Ahrén (born 1952), holds a doctorate of medicine and is a registered physician. Since 1995 he has been professor of Clinical Metabolism at the Faculty of Medicine at Lund University. Since 2000 he is a consultant at the Department of Endocrinology and Lund University Hospital. During the years 2004-2005 he was the Chief Physician at the Region of Skåne in Sweden.
Bo Ahrén is an active researcher within the field of diabetology. He has published more than 600 original scientific articles and review articles within the are of insulin secretion. His research has during recent years concentrated on incretin actions with particular emphases on developing new treatment for type 2 diabetes based on the incretin hormone GLP-1.
Bo Ahrén has since 2006 been the Dean of the Faculty of Medicine at Lund University.
Niels Borregaard
Member of the board of directors of the Novo Nordisk Foundation since 2000. Niels Borregaard is chairman of the Novo Nordisk Foundation's committee for Health and Natural Sciences since 2000 and member of the Novo Nordisk Foundation's price committee since 1997.
Niels Borregaard, MD, (born 1951), board certified in internal medicine and hematology, dr. med. 1982.
Niels Borregaard is member of the board of trustees of the Alfred Benzon Foundation, and the Svend Andersen Foundation. Niels Borregaard is member of the research council at the Faculty of Health Sciences, University of Copenhagen, the reseach council at Rigshospitalet and the research council at The Capital Region of Denmark; member of Council of Academic Affairs, Faculty of Health Sciences, University of Copenhagen since 2006, member of Executive Council for University Hospitals, Faculty of Health Sciences, University of Copenhagen since 2007.
Editor-in-chief, European Journal of Haematology since 2000
He is also member of the board of Steno Diabetes Center since 2000.
Niels Borregaard is professor of hematology University of Copenhagen and chairman Department of Hematology Rigshospitalet since 1998.
Niels Borregaard, MD, (born 1951), board certified in internal medicine and hematology, dr. med. 1982.
Niels Borregaard is member of the board of trustees of the Alfred Benzon Foundation, and the Svend Andersen Foundation. Niels Borregaard is member of the research council at the Faculty of Health Sciences, University of Copenhagen, the reseach council at Rigshospitalet and the research council at The Capital Region of Denmark; member of Council of Academic Affairs, Faculty of Health Sciences, University of Copenhagen since 2006, member of Executive Council for University Hospitals, Faculty of Health Sciences, University of Copenhagen since 2007.
Editor-in-chief, European Journal of Haematology since 2000
He is also member of the board of Steno Diabetes Center since 2000.
Niels Borregaard is professor of hematology University of Copenhagen and chairman Department of Hematology Rigshospitalet since 1998.
Karsten Dybvad
Elected to the board of the Novo Nordisk Foundation 6 May, 2011.
Karsten Dybvad (born 1956) holds a masters degree in Economics and has since 2010 been Director General and CEO of DI (Confederation of Danish Industry).
Ulla Morin
Employee-elected member of the board of the Novo Nordisk Foundation since 2002.
Ulla Morin (born 1954), has been working with Novozymes since 1990 as a Laboratory Technician.
Employee-elected member of the board of the Novo Nordisk Foundation since 2002.
Ulla Morin (born 1954), has been working with Novozymes since 1990 as a Laboratory Technician.
Kurt Anker Nielsen
Elected to the board of the Novo Nordisk Foundation in 2006.
Kurt Anker Nielsen (born 1945), MSc in Commerce and Business Administration from the Copenhagen Business School, Denmark, from 1972.
Kurt Anker Nielsen is former CFO and deputy CEO of Novo Nordisk A/S and former CEO of Novo A/S.
Vice chairman of the Board of Novozymes A/S and as a member of the boards of Novo Nordisk A/S, Denmark.
He serves as chairman of the Board of Reliance A/S, Denmark and Collstrup's Mindelegat, Denmark.
Mr Nielsen also serves as member of the Board of Directors in LifeCycle Pharma A/S, Denmark and Vestas Wind Systems A/S, Denmark. In the three last-mentioned companies he is also the elected Audit Committee chairman.
Søren Thuesen Pedersen
Member of the board of the Novo Nordisk Foundation since 2002 and an employee-elected member of the board of Novo Nordisk A/S since 2006.
Søren Thuesen Pedersen (born 1964), BSc in Chemical Engineering from the Danish Academy of Engineers from 1988. Until 1994 he worked as a Manager in Nycomed DAK (chemical and analytical Development).
Søren Thuesen Pedersen joined Novo Nordisk in 1994, he has mainly worked as a manager in Marketed Products and as a specialist and coordinator on External Affairs.
He is currently working as a specialist in Global Quality Development, External Affairs.
Member of the board of the Novo Nordisk Foundation since 2002 and an employee-elected member of the board of Novo Nordisk A/S since 2006.
Søren Thuesen Pedersen (born 1964), BSc in Chemical Engineering from the Danish Academy of Engineers from 1988. Until 1994 he worked as a Manager in Nycomed DAK (chemical and analytical Development).
Søren Thuesen Pedersen joined Novo Nordisk in 1994, he has mainly worked as a manager in Marketed Products and as a specialist and coordinator on External Affairs.
He is currently working as a specialist in Global Quality Development, External Affairs.
Stig Strøbæk
Employee-elected member of the board of the Novo Nordisk Foundation and of the board of Novo Nordisk A/S since 1998.
Mr Strøbæk (born 1964). Mr Strøbæk has a diploma as an electrician. He also has a diploma in further training for board members from the Danish Employees' Capital Pension Fund (LD) from 2003.
He is currently working in Product Supply as an electrician.
Employee-elected member of the board of the Novo Nordisk Foundation and of the board of Novo Nordisk A/S since 1998.
Mr Strøbæk (born 1964). Mr Strøbæk has a diploma as an electrician. He also has a diploma in further training for board members from the Danish Employees' Capital Pension Fund (LD) from 2003.
He is currently working in Product Supply as an electrician.